We are pleased to announce the appointment of Mr. Christian Carswell as CEO in MSC’s leadership team, building upon a skilled organization to drive growth and profitability for our cannabis product scientific advisory & contract lab services.


“Christian brings an executive track record of successful global pharmaceutical licensing ventures and Canadian government policy in the applied fields of oncology, plant biology & genomics databases¬† – a skilled entrepreneurial leader for MSC”

Ian Morton, COO


Christian joins MSC after having spent the past twenty years in the life sciences sector. His experience spans agricultural chemicals, the pharmaceutical industry, health research organizations, and consulting for emerging life sciences companies. Christian founded a company engaged in pharmaceutical and consumer health product development, manufacturing and distribution, working with partners and clients in markets around the world, including China, India, Europe and North America.  He also built and managed a private fund that invests in publicly traded, small and mid-cap life sciences companies.

Christian has held executive leadership positions in the public and not-for-profit sectors; as CEO of BioCanRx, a funder of cancer biologics R&D; head of the life sciences group at Global Affairs Canada, helping Canadian health technology companies to pursue international business opportunities; and Director of the Genomic Applications Partnerships fund at Genome Canada, investing in genomics R&D in health, agriculture and other fields. Most recently, he has used his network in industry, academia, healthcare and government to advance interests in a range of areas, including oncology, precision medicine, and funding for Canadian innovation.